Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-γ+CD4+ T cell numbers during colitis development in mice

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2780-2795

  Maseda, Damian ^a   Candando, Kathleen M ^a   Smith, Susan H ^a   Kalampokis, Ioannis ^a   Weaver, Casey T ^b,c   Plevy, Scott E ^d   Poe, Jonathan C ^a   Tedder, Thomas F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CELL SURFACE; COLITIS; COMMENSAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FETUS; GASTROINTESTINAL TRACT; GERM LINE; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INTESTINE FLORA; LIVER CELL; MALE; MOUSE; MUCOSAL IMMUNITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOPHYSIOLOGY; PERITONEAL CAVITY; PHENOTYPE; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; B-LYMPHOCYTES, REGULATORY; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; INTERFERON-GAMMA; INTERLEUKIN-10; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERITONEAL CAVITY;

EID: 84883441574     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300649     Document Type: Article

References (72)

1. Maynard, C. L., and C. T. Weaver. 2009. Intestinal effector T cells in health and disease. Immunity 31: 389-400.
2. Abraham, C., and J. Cho. 2009. Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm. Bowel Dis. 15: 1090-1100.
3. Nemoto, Y., T. Kanai, K. Kameyama, T. Shinohara, N. Sakamoto, T. Totsuka, R. Okamoto, K. Tsuchiya, T. Nakamura, T. Sudo, et al. 2009. Long-lived colitogenic CD4+ memory T cells residing outside the intestine participate in the perpetuation of chronic colitis. J. Immunol. 183: 5059-5068.
4. Asseman, C., S. Read, and F. Powrie. 2003. Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. J. Immunol. 171: 971-978.
5. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765.
6. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
7. Murai, M., O. Turovskaya, G. Kim, R. Madan, C. L. Karp, H. Cheroutre, and M. Kronenberg. 2009. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 10: 1178-1184.
8. Rubtsov, Y. P., J. P. Rasmussen, E. Y. Chi, J. Fontenot, L. Castelli, X. Ye, P. Treuting, L. Siewe, A. Roers, W. R. Henderson, Jr., et al. 2008. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28: 546-558.
9. + T cells. Immunity 1: 553-562.
10. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004.
11. Franke, A., T. Balschun, T. H. Karlsen, J. Sventoraityte, S. Nikolaus, G. Mayr, F. S. Domingues, M. Albrecht, M. Nothnagel, D. Ellinghaus, et al. 2008. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet. 40: 1319-1323.
12. Aithal, G. P., A. Craggs, C. P. Day, M. Welfare, A. K. Daly, J. C. Mansfield, and M. Hudson. 2001. Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflammatory bowel disease. Dig. Dis. Sci. 46: 1520-1525.
13. Asadullah, K., W. Sterry, and H. D. Volk. 2003. Interleukin-10 therapy-review of a new approach. Pharmacol. Rev. 55: 241-269.
14. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146: 3444-3451.
15. Leiper, K., K. Martin, A. Ellis, S. Subramanian, A. J. Watson, S. E. Christmas, D. Howarth, F. Campbell, and J. M. Rhodes. 2011. Randomised placebocontrolled trial of rituximab (anti-CD20) in active ulcerative colitis. Gut 60: 1520-1526.
16. El Fassi, D., C. H. Nielsen, J. Kjeldsen, O. Clemmensen, and L. Hegedus. 2008. Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease. Gut 57: 714-715.
17. Goetz, M., R. Atreya, M. Ghalibafian, P. R. Galle, and M. F. Neurath. 2007. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm. Bowel Dis. 13: 1365-1368.
18. Mizoguchi, A., E. Mizoguchi, R. N. Smith, F. I. Preffer, and A. K. Bhan. 1997. Suppressive role of B cells in chronic colitis of T cell receptor a mutant mice. J. Exp. Med. 186: 1749-1756.
19. Mizoguchi, A., and A. K. Bhan. 2006. A case for regulatory B cells. J. Immunol. 176: 705-710.
20. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230.
21. Schmidt, E. G., H. L. Larsen, N. N. Kristensen, S. S. Poulsen, M. H. Claesson, and A. E. Pedersen. 2012. B cells exposed to enterobacterial components suppress development of experimental colitis. Inflamm. Bowel Dis. 18: 284-293.
22. Yanaba, K., A. Yoshizaki, Y. Asano, T. Kadono, T. F. Tedder, and S. Sato. 2011. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am. J. Pathol. 178: 735-743.
23. Iwata, Y., T. Matsushita, M. Horikawa, D. J. DiLillo, K. Yanaba, G. M. Venturi, P. M. Szabolcs, S. H. Bernstein, C. M. Magro, A. D. Williams, et al. 2011. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117: 530-541.
24. + phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650.
25. Matsushita, T., K. Yanaba, J.-D. Bouaziz, M. Fujimoto, and T. F. Tedder. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118: 3420-3430.
26. DiLillo, D. J., T. Matsushita, and T. F. Tedder. 2010. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann. N. Y. Acad. Sci. 1183: 38-57.
27. Ray, A., S. Basu, C. B. Williams, N. H. Salzman, and B. N. Dittel. 2012. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J. Immunol. 188: 3188-3198.
28. Yanaba, K., J. D. Bouaziz, T. Matsushita, T. Tsubata, and T. F. Tedder. 2009. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 182: 7459-7472.
29. Matsushita, T., M. Horikawa, Y. Iwata, and T. F. Tedder. 2010. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling EAE initiation and late-phase immunopathogenesis. J. Immunol. 185: 2240-2252.
30. 1 mice. J. Immunol. 184: 4789-4800.
31. Horikawa, M., V. Minard-Colin, T. Matsushita, and T. F. Tedder. 2011. Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. J. Clin. Invest. 121: 4268-4280.
32. Yoshizaki, A., T. Miyagaki, D. J. DiLillo, T. Matsushita, M. Horikawa, E. I. Kountikov, R. Spolski, J. C. Poe, W. J. Leonard, and T. F. Tedder. 2012. Regulatory B cells control T cell autoimmunity through IL-21-dependent cognate interactions. Nature 491: 264-268.
33. Horikawa, M., E. T. Weimer, D. J. DiLillo, G. M. Venturi, R. Spolski, W. J. Leonard, M. T. Heise, and T. F. Tedder. 2013. Regulatory B cell (B10 cell) expansion during Listeria infection governs innate and cellular immune responses in mice. J. Immunol. 190: 1158-1168.
34. Xiu, Y., C. P. Wong, Y. Hamaguchi, Y. Wang, S. Pop, R. M. Tisch, and T. F. Tedder. 2008. B lymphocytes depletion by CD20 monoclonal antibody prevents diabetes in NOD mice despite isotype-specific differences in FcγR effector functions. J. Immunol. 180: 2863-2875.
35. Kalampokis, I., A. Yoshizaki, and T. F. Tedder. 2013. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res. Ther. 15(Suppl. 1): S1.
36. O'Garra, A., R. Chang, N. Go, R. Hastings, G. Haughton, and M. Howard. 1992. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22: 711-717.
37. Nakashima, H., Y. Hamaguchi, R. Watanabe, N. Ishiura, Y. Kuwano, H. Okochi, Y. Takahashi, K. Tamaki, S. Sato, T. F. Tedder, and M. Fujimoto. 2010. CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions. J. Immunol. 184: 4637-4645.
38. Kamanaka, M., S. T. Kim, Y. Y. Wan, F. S. Sutterwala, M. Lara-Tejero, J. E. Galan, E. Harhaj, and R. A. Flavell. 2006. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25: 941-952.
39. Shinkai, Y., G. Rathbun, K. P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, and F.W. Alt. 1992. RAG-2 deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
40. - precursor cells in the absence of interleukin 10. Nat. Immunol. 8: 931-941.
41. Sato, S., N. Ono, D. A. Steeber, D. S. Pisetsky, and T. F. Tedder. 1996. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157: 4371-4378.
42. Matsushita, T., and T. F. Tedder. 2011. Identifying regulatory B cells (B10 cells) that produce IL-10. Methods Mol. Biol. 677: 99-111.
43. Rohatgi, S., P. Ganju, and D. Sehgal. 2008. Systematic design and testing of nested (RT-)PCR primers for specific amplification of mouse rearranged/expressed immunoglobulin variable region genes from small number of B cells. J. Immunol. Methods 339: 205-219.
44. Brochet, X., M. P. Lefranc, and V. Giudicelli. 2008. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36: W503-508.
45. Chenna, R., H. Sugawara, T. Koike, R. Lopez, T. J. Gibson, D. G. Higgins, and J. D. Thompson. 2003. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31: 3497-3500.
46. Maseda, D., S. H. Smith, D. J. DiLillo, J. M. Bryant, K. M. Candando, C. T. Weaver, and T. F. Tedder. 2012. Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J. Immunol. 188: 1036-1048.
47. Chinen, T., K. Komai, G. Muto, R. Morita, N. Inoue, H. Yoshida, T. Sekiya, R. Yoshida, K. Nakamura, R. Takayanagi, and A. Yoshimura. 2011. Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance. Nat. Commun. 2: 190.
48. Haas, K. M., J. C. Poe, D. A. Steeber, and T. F. Tedder. 2005. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23: 7-18.
49. H sequences from B1-a, B1-b, and conventional B cells. J. Immunol. 158: 1175-1186.
50. Arnold, L. W., C. A. Pennell, S. K. McCray, and S. H. Clarke. 1994. Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J. Exp. Med. 179: 1585-1595.
51. Neves, P., V. Lampropoulou, E. Calderon-Gomez, T. Roch, U. Stervbo, P. Shen, A. A. Kuhl, C. Loddenkemper, M. Haury, S. A. Nedospasov, et al. 2010. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33: 777-790.
52. Blair, P. A., K. A. Chavez-Rueda, J. G. Evans, M. J. Shlomchik, A. Eddaoudi, D. A. Isenberg, M. R. Ehrenstein, and C. Mauri. 2009. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J. Immunol. 182: 3492-3502.
53. hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32: 129-140.
54. Poe, J. C., S.-H. Smith, K. M. Haas, K. Yanaba, T. Tsubata, T. Matsushita, and T. F. Tedder. 2011. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS ONE 6: e22464.
55. Matsumoto, M., Y. Fujii, A. Baba, M. Hikida, T. Kurosaki, and Y. Baba. 2011. The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity 34: 703-714.
56. Scapini, P., C. Lamagna, Y. Hu, K. Lee, Q. Tang, A. L. DeFranco, and C. A. Lowell. 2011. B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice. Proc. Natl. Acad. Sci. USA 108: E823-E832.
57. Ding, Q., M. Yeung, G. Camirand, Q. Zeng, H. Akiba, H. Yagita, G. Chalasani, M. H. Sayegh, N. Najafian, and D. M. Rothstein. 2011. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J. Clin. Invest. 121: 3645-3656.
58. H11 family. J. Immunol. 142: 3643-3651.
59. Seidl, K. J., J. D. MacKenzie, D. Wang, A. B. Kantor, E. A. Kabat, L. A. Herzenberg, and L. A. Herzenberg. 1997. Frequent occurrence of identical heavy and light chain Ig rearrangements. Int. Immunol. 9: 689-702.
60. O'Garra, A., and M. Howard. 1992. IL-10 production by CD5 B cells. Ann. N. Y. Acad. Sci. 651: 182-199.
61. Fillatreau, S. 2011. Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection. Immunol. Rev. 240: 52-71.
62. Hardy, R. R. 2006. B-1 B cell development. J. Immunol. 177: 2749-2754.
63. Dorshkind, K., and E. Montecino-Rodriguez. 2007. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat. Rev. Immunol. 7: 213-219.
64. Esplin, B. L., R. S. Welner, Q. Zhang, L. A. Borghesi, and P. W. Kincade. 2009. A differentiation pathway for B1 cells in adult bone marrow. Proc. Natl. Acad. Sci. USA 106: 5773-5778.
65. Ha, S. A., M. Tsuji, K. Suzuki, B. Meek, N. Yasuda, T. Kaisho, and S. Fagarasan. 2006. Regulation of B1 cell migration by signals through Toll-like receptors. J. Exp. Med. 203: 2541-2550.
66. Mizoguchi, E., A. Mizoguchi, F. I. Preffer, and A. K. Bhan. 2000. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int. Immunol. 12: 597-605.
67. Shimomura, Y., E. Mizoguchi, K. Sugimoto, R. Kibe, Y. Benno, A. Mizoguchi, and A. K. Bhan. 2008. Regulatory role of B-1 B cells in chronic colitis. Int. Immunol. 20: 729-737.
68. + T cell colitis through interaction with regulatory T cell subsets. Proc. Natl. Acad. Sci. USA 102: 2010-2015.
69. Berberich, S., R. Forster, and O. Pabst. 2007. The peritoneal micromilieu commits B cells to home to body cavities and the small intestine. Blood 109: 4627-4634.
70. Feng, T., L. Wang, T. R. Schoeb, C. O. Elson, and Y. Cong. 2010. Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J. Exp. Med. 207: 1321-1332.
71. 2 class switching by inducing epithelialcell secretion of the cytokine APRIL. Immunity 26: 812-826.
72. Round, J. L., and S. K. Mazmanian. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9: 313-323.